Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease

Kidney International

Volumn 69, Issue 10, 2006, Pages 1722-1725

  Nakagawa, T ^a   Kang, D H ^b   Feig, D ^c   Sanchez Lozada, L G ^d   Srinivas, T R ^a   Sautin, Y ^a   Ejaz, A A ^a   Segal, M ^a   Johnson, R J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b Ewha Womans University   (South Korea)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Arteriolosclerosis; Chronic kidney disease; Hypertension; Metabolic syndrome; Transplant associated kidney disease

Indexed keywords

URIC ACID;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TRANSPLANT ASSOCIATED KIDNEY DISEASE;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY DISEASES; URIC ACID;

EID: 33646674298     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000391     Document Type: Short Survey

References (31)

1. Vaccarino V, Krumholz HM. Risk factors for cardiovascular disease: one down, many more to evaluate. Ann Int Med 1999; 131: 62-63.
2. Beck L. Requiem for gouty nephropathy. Kidney Int 1986; 30: 280-287.
3. Johnson RJ, Kivlighn SD, Kim Y-G et al. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular and renal disease. Am J Kidney Dis 1999; 33: 225-234.
4. Johnson RJ, Tuttle KR. Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease. Hypertension 2000; 35: E10. http://www.hypertensionaha. org.
5. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol 2005; 70: 343-354.
6. Nieto FJ, Iribarren C, Gross MD et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000; 148: 131-139.
7. Watanabe S, Kang D-H, Feng L et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40: 355-360.
8. Kanellis J, Watanabe S, Li JH et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-1293.
9. Kang D-H, Nakagawa T, Feng L et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13: 2888-2897.
10. Kang D-H, Park SK, Lee IK, Johnson RJ. Uric acid induced C-reactive protein (CRP) expression: Implication on cell proliferation and nitric oxide production in human vascular cells. J Am Soc Nephrol 2005; 16: 3553-3562.
11. Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-1742.
12. Santos CXC, Anjos EI, Augusto O. Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 1999; 372: 285-294.
13. Mazzali M, Hughes J, Kim YG et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101-1106.
14. Mazzali M, Kanellis J, Han L et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282: F991-F997.
15. Johnson RJ, Feig DI, Kang DH, Herrera-Acosta J. Resurrection of uric acid as a causal risk factor for essential hypertension. Hypertension 2005; 45: 18-20.
16. Feig DI, Johnson RJ. Hyperuricemia in childhood essential hypertension. Hypertension 2003; 42: 247-252.
17. Feig DI, Nakagawa T, Karumanchi SA et al. Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004; 66: 281-287.
18. Elliott SS, Keim NL, Stern JS et al. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002; 76: 911-912.
19. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 2005; 1: 80-86.
20. Nakagawa T, Hu H, Zharikov S et al. Uric acid as a causal factor for fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625-F631.
21. Masuo K, Kawaguchi H, Mikami H et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-480.
22. Nakagawa T, Mazzali M, Kang D-H et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 2003; 23: 2-7.
23. Sanchez-Lozada LG, Tapia E, Santamaria J et al. Mild hyperuricemia induces severe cortical vasoconstriction and perpetuates glomerular hypertension in normal rats and in experimental chronic renal failure. Kidney Int 2005; 67: 237-247.
24. Iseki K, Oshiro S, Tozawa M et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001; 24: 691-697.
25. Siu YP, Leung KT, Tong MKH, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability in lowering serum uric acid level. Am J Kid Dis 2006; 47: 51-59.
26. Mazzali M, Kim YG, Suga S et al. Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation 2001; 71: 900-905.
27. Assis SM, Monteiro JL, Seguro AC. -Arginine and allopurinol protect against cyclosporine nephrotoxicity. Transplantation 1997; 63: 1070-1073.
28. Neal DA, Tom BD, Gimson AE et al. Hyperuricemia, gout, and renal function after liver transplantation. Transplantation 2001; 72: 1689-1691.
29. Abbott KC, Kimmel PL, Dharnidharka V et al. New-onset gout after kidney transplantation: Incidence, Risk Factors, and Implications. Transplantation 2005; 80: 1385-1391.
30. Kang D-H, Finch J, Nakagawa T et al. Uric acid, endothelial dysfunction, and preeclampsia: searching for a pathogenetic link. J Hypertens 2004; 22: 229-235.
31. Mercuro G, Vitale C, Cerquetani E et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004; 94: 932-935.